Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$549K Buy
20,116
+14,229
+242% +$390K ﹤0.01% 4168
2014
Q2
$169K Buy
5,887
+3,116
+112% +$84.1K ﹤0.01% 5318
2014
Q1
$79K Sell
2,771
-384
-12% -$10.5K ﹤0.01% 6285
2013
Q4
$81K Sell
3,155
-1,519
-32% -$36.3K ﹤0.01% 6327
2013
Q3
$110K Buy
4,674
+1,874
+67% +$41.8K ﹤0.01% 5903
2013
Q2
$58K Buy
+2,800
New +$51.7K ﹤0.01% 6551

Other funds holding OMCL

UBS's OMCL Position: Q3 2014 in Review

UBS increased its Omnicell (OMCL) stake by 242% in Q3 2014, buying an estimated $390K and bringing the position to 20,116 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #4168.

UBS first reported a position in OMCL in Q2 2013 and has held it in 6 quarters since. 177 funds tracked by Wall St. Rank hold OMCL as of Q3 2014.

  • UBS held 20,116 shares of Omnicell worth $549K as of Q3 2014.
  • UBS bought 14,229 Omnicell shares in Q3 2014, an estimated $390K.
  • Omnicell made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4168 holding.
  • UBS first reported a position in Omnicell in Q2 2013 and has held it in 6 quarters since.
  • 177 funds tracked by Wall St. Rank held Omnicell as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.